Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously

Not intended for US, Canada and UK-based media DARMSTADT, Germany and NEW YORK, March 19, 2019 /PRNewswire/ -- Merck and Pfizer Inc. today announced the discontinuation ... Lees verder

Bron:

ANP Pers support